An inhaled glucocorticoid does not prevent tolerance to the bronchoprotective effect of a long-acting inhaled β2-agonist

American Journal of Respiratory and Critical Care Medicine

Volumn 154, Issue 6, 1996, Pages 1603-1607

  Yates, D H ^a   Kharitonov, S A ^a   Barnes, P J ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BUDESONIDE; METHACHOLINE; SALBUTAMOL; SALMETEROL;

ADULT; ARTICLE; ASTHMA; BRONCHOSPASM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DAILY LIFE ACTIVITY; DOSIMETRY; DOUBLE BLIND PROCEDURE; DOWN REGULATION; FEMALE; HUMAN; HYPERSENSITIVITY; INHALATIONAL DRUG ADMINISTRATION; LUNG PARENCHYMA; MALE; PATIENT CARE; PRIORITY JOURNAL; PROVOCATION TEST; RANDOMIZED CONTROLLED TRIAL;

EID: 0030479464     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.154.6.8970342     Document Type: Article

References (0)